Cargando…

RUCAM in Drug and Herb Induced Liver Injury: The Update

RUCAM (Roussel Uclaf Causality Assessment Method) or its previous synonym CIOMS (Council for International Organizations of Medical Sciences) is a well established tool in common use to quantitatively assess causality in cases of suspected drug induced liver injury (DILI) and herb induced liver inju...

Descripción completa

Detalles Bibliográficos
Autores principales: Danan, Gaby, Teschke, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730261/
https://www.ncbi.nlm.nih.gov/pubmed/26712744
http://dx.doi.org/10.3390/ijms17010014
_version_ 1782412361815031808
author Danan, Gaby
Teschke, Rolf
author_facet Danan, Gaby
Teschke, Rolf
author_sort Danan, Gaby
collection PubMed
description RUCAM (Roussel Uclaf Causality Assessment Method) or its previous synonym CIOMS (Council for International Organizations of Medical Sciences) is a well established tool in common use to quantitatively assess causality in cases of suspected drug induced liver injury (DILI) and herb induced liver injury (HILI). Historical background and the original work confirm the use of RUCAM as single term for future cases, dismissing now the term CIOMS for reasons of simplicity and clarity. RUCAM represents a structured, standardized, validated, and hepatotoxicity specific diagnostic approach that attributes scores to individual key items, providing final quantitative gradings of causality for each suspect drug/herb in a case report. Experts from Europe and the United States had previously established in consensus meetings the first criteria of RUCAM to meet the requirements of clinicians and practitioners in care for their patients with suspected DILI and HILI. RUCAM was completed by additional criteria and validated, assisting to establish the timely diagnosis with a high degree of certainty. In many countries and for more than two decades, physicians, regulatory agencies, case report authors, and pharmaceutical companies successfully applied RUCAM for suspected DILI and HILI. Their practical experience, emerging new data on DILI and HILI characteristics, and few ambiguous questions in domains such alcohol use and exclusions of non-drug causes led to the present update of RUCAM. The aim was to reduce interobserver and intraobserver variability, to provide accurately defined, objective core elements, and to simplify the handling of the items. We now present the update of the well accepted original RUCAM scale and recommend its use for clinical, regulatory, publication, and expert purposes to validly establish causality in cases of suspected DILI and HILI, facilitating a straightforward application and an internationally harmonized approach of causality assessment as a common basic tool.
format Online
Article
Text
id pubmed-4730261
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-47302612016-02-11 RUCAM in Drug and Herb Induced Liver Injury: The Update Danan, Gaby Teschke, Rolf Int J Mol Sci Review RUCAM (Roussel Uclaf Causality Assessment Method) or its previous synonym CIOMS (Council for International Organizations of Medical Sciences) is a well established tool in common use to quantitatively assess causality in cases of suspected drug induced liver injury (DILI) and herb induced liver injury (HILI). Historical background and the original work confirm the use of RUCAM as single term for future cases, dismissing now the term CIOMS for reasons of simplicity and clarity. RUCAM represents a structured, standardized, validated, and hepatotoxicity specific diagnostic approach that attributes scores to individual key items, providing final quantitative gradings of causality for each suspect drug/herb in a case report. Experts from Europe and the United States had previously established in consensus meetings the first criteria of RUCAM to meet the requirements of clinicians and practitioners in care for their patients with suspected DILI and HILI. RUCAM was completed by additional criteria and validated, assisting to establish the timely diagnosis with a high degree of certainty. In many countries and for more than two decades, physicians, regulatory agencies, case report authors, and pharmaceutical companies successfully applied RUCAM for suspected DILI and HILI. Their practical experience, emerging new data on DILI and HILI characteristics, and few ambiguous questions in domains such alcohol use and exclusions of non-drug causes led to the present update of RUCAM. The aim was to reduce interobserver and intraobserver variability, to provide accurately defined, objective core elements, and to simplify the handling of the items. We now present the update of the well accepted original RUCAM scale and recommend its use for clinical, regulatory, publication, and expert purposes to validly establish causality in cases of suspected DILI and HILI, facilitating a straightforward application and an internationally harmonized approach of causality assessment as a common basic tool. MDPI 2015-12-24 /pmc/articles/PMC4730261/ /pubmed/26712744 http://dx.doi.org/10.3390/ijms17010014 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Danan, Gaby
Teschke, Rolf
RUCAM in Drug and Herb Induced Liver Injury: The Update
title RUCAM in Drug and Herb Induced Liver Injury: The Update
title_full RUCAM in Drug and Herb Induced Liver Injury: The Update
title_fullStr RUCAM in Drug and Herb Induced Liver Injury: The Update
title_full_unstemmed RUCAM in Drug and Herb Induced Liver Injury: The Update
title_short RUCAM in Drug and Herb Induced Liver Injury: The Update
title_sort rucam in drug and herb induced liver injury: the update
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730261/
https://www.ncbi.nlm.nih.gov/pubmed/26712744
http://dx.doi.org/10.3390/ijms17010014
work_keys_str_mv AT danangaby rucamindrugandherbinducedliverinjurytheupdate
AT teschkerolf rucamindrugandherbinducedliverinjurytheupdate